Latest Headlines

  1. Philips To Acquire Brain Monitoring Company Electrical Geodesics, Inc.
    6/22/2017

    Royal Philips , a global leader in health technology, recently announced an agreement to acquire Electrical Geodesics, Inc. (EGI), a US-based medical device company that designs, develops and commercializes a range of non-invasive technologies used to monitor and interpret brain activity. EGI’s portfolio of EEG hardware, software and acquisition sensors will complement Philips’ existing portfolio of imaging technologies (e.g. MRI and PET-CT) and advanced informatics (e.g. IntelliSpace Portal) for neurological applications.

  2. FDA Clears First RF Ablation Treatment For Osteoarthritis Knee Pain
    6/20/2017

    The U.S. Food and Drug Administration (FDA) has approved the first and only radio frequency (RF) treatment to be cleared specifically to alleviate chronic knee pain due to osteoarthritis.

  3. MKS' Ophir® Business Unit Announces Large Array Laser Beam Profiling Camera With Quick And Easy USB Interfacing
    6/1/2017

    MKS Instruments, Inc., a global provider of technologies that enable advanced processes and improve productivity, has announced the Ophir® Pyrocam™ IV USB, a laser beam profiling camera that allows users to see their laser beam for dynamic alignment and proper operation. The camera features a 320 x 320 pixel pyroelectric array that can profile beams up to 1 inch (25 mm) without the need for reduction optics. It also includes a new USB 3.0 interface that provides a quick and easy connection to PCs for beam analysis, 2D and 3D beam display, as well as trending, data logging, and storage.

  4. Exactech’s Computer-Assisted Shoulder Arthroplasty Tech Gains FDA Clearance
    5/15/2017

    Exactech, Inc., a developer and producer of bone and joint restoration products and biologic solutions for extremities, knee and hip, announced recently it has received clearance from the U.S. Food and Drug Administration to market the ExactechGPS Shoulder Application

  5. FDA Grants HUD Designation To Novocure’s Tumor Treating Fields (TTFields) Delivery System
    5/15/2017

    Novocure announced recently that United States Food and Drug Administration (FDA) has designated it’s Tumor Treating Fields (TTFields) delivery system as a Humanitarian Use Device (HUD) for the treatment of pleural mesothelioma.

  6. Shockwave Medical’s Coronary Lithoplasty System Earns CE Mark
    5/15/2017

    Shockwave Medical, a pioneer in the treatment of calcified cardiovascular disease, recently announced conformité européenne (CE) Mark for the company’s Coronary Lithoplasty System for the treatment of calcified plaque in conjunction with stenting in patients with coronary artery disease.

  7. Cook Medical’s Esophogeal Repair Device For Infants Cleared By FDA
    5/12/2017

    The U.S. Food and Drug Administration today authorized use of the Flourish Pediatric Esophageal Atresia Anastomosis, a first-of-its-kind medical device to treat infants up to one year old for a birth defect that causes a gap in their esophagus, called esophageal atresia.

  8. Medtronic Options QT Vascular’s Chocolate PTA Balloon Catheter
    5/11/2017

    QT Vascular Ltd., (the "Company" or "QT Vascular", and together with its subsidiaries, the "Group"), a global company engaged in the design, assembly and distribution of advanced therapeutic solutions for the minimally invasive treatment of vascular disease, announced today that it has entered into an asset purchase option agreement ("Option Agreement") with Medtronic, for the acquisition of the Group's non-drug coated Chocolate® PTA.

  9. Cook Medical Sells Vertebroplasty Products To IZI Medical
    5/10/2017

    Cook Medical is pleased to announce the sale of its comprehensive family of vertebroplasty products to IZI Medical Products, LLC.

  10. Siemens Healthineers, Imricor Team On Integrated Solution To Treat Arrhythmia
    5/10/2017

    Siemens Healthineers is joining forces with U.S.-based Imricor Medical Systems Inc. to develop an integrated solution that combines the clinical benefits of real-time MRI scans with 3D-guided cardiac ablation.